Tag Archives: Bistos

Keeping tabs: When is antepartum fetal monitoring important?

Thanks to innovations in technology, antepartum fetal monitors have come a long way since the 1970s.

Today’s equipment is highly valuable in detecting heartbeat irregularities in fetuses in their last trimesters subject to increased risk of stillbirth. Often used in conjunction with real-time ultrasonography and umbilical artery Doppler velocimetry, the monitors can accurately inform on whether intervention is needed to restore a normal heartbeat and/or prevent intrauterine injury or neurological damage.

“In most cases, a normal antepartum fetal test result is highly reassuring, as reflected in the low false-negative rate of antepartum fetal surveillance,” notes a recent bulletin by the International Journal of Obstetrics and Gynecology Research. “Theoretic models and large clinical studies suggest initiating antepartum fetal testing no earlier than 32 0/7 weeks of gestation is appropriate for most at-risk patients. However, in pregnancies with multiple or particularly worrisome high-risk conditions (e.g., chronic hypertension with suspected fetal growth restriction), testing might begin at a gestational age when delivery would be considered for perinatal benefit.”

BT-350The monitors are typically recommended when the pregnant woman exhibits the following, reports American Family Physician:

  • Maternal conditions such as antiphospholipid syndrome; poorly controlled hyperthyroidism; hemoglobinopathies such as hemoglobin SS, SC or S-thalassemia; cyanotic heart disease; systemic lupus erythematosus; chronic renal disease; type 1 diabetes mellitus or hypertensive disorders.
  • Pregnancy-related conditions such as pregnancy-induced hypertension; decreased fetal movement; oligohydramnios; polyhydramnios; intrauterine growth restriction; post-term pregnancy; moderate to severe isoimmunization; previous fetal demise or multiple gestation with significant growth discrepancy.

Our Advanced Antepartum Fetal Monitor BT350 offers ease of use and accuracy through its 7-inch TFT color LCD monitor, waterproof probes, rechargeable built-in battery, storage capacity for 450 hours of patient data at any given time and ability to network with a PC (RS-232 or optional Bluetooth).

Phototherapy for newborn jaundice treatment

Jaundice, which commonly shows up in infants as the yellowish pigmentation of the skin due to high bilirubin levels in the blood, can be caused by a number of different medical conditions.

Many new or expectant parents are surprised to learn how common jaundice is in newborn babies. According to research in The New England Journal of Medicine, jaundice shows up in approximately 60 percent of all newborn babies within the first week.

In most cases, infants exhibit nonpathological, or physiologic, jaundice that is not connected to any serious medical condition. Nonetheless, if untreated, the rising bilirubin levels may lead to further complications.

Fortunately, this common condition is easy to treat through phototherapy. The process is remarkably simple: specialized light is used to convert the excess bilirubin into water-soluble isomers the infant’s body can excrete.

BT-400_imageTo be effective, phototherapy needs to employ a specific kind of light that can be absorbed by the infant. One of the most effective treatments available, the BT-400, uses blue-light phototherapy, a far more effective treatment option than either halogen or ultraviolet lights.

The BT-400 is lightweight, compact, has two adjustable levels of intensity and boasts an incredible 20,000 hours of operating time. Because neonatal jaundice is so common, this simple and highly effective instrument has a place in any practice that treats infants or families.​